Amgen MedDRA Query narrow searches were performed to supplement standard system organ class single preferred term safety reporting (defined in Data Supplement and summarized in Table 2). Measures to ...

Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers federal public health agencies. The Food and Drug Administration is drawing up plans that would end ...

India Pakistan News LIVE Updates: India and Pakistan will continue the confidence-building measures agreed between their two top military officers to end the brief ...

The company offers branded and private-label products in a range of merchandise categories. Costco Wholesale stock traded up $15.36 during mid-day trading on Friday, hitting $1,025.83. The stock ...

He fled through a rear emergency exit of the store, without any attempt to pay for the merchandise. This suspect is being sought in a theft at Walgreens at Lake Deaton Plaza. He is described as a ...

Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse portfolios. Amgen boasts one of the largest portfolios in the biotech industry ...

Amar, Prem, Teja, Gogo aren’t just characters but merchandise worth flaunting.Last week, the Delhi High Court issued an ex-parte, ad-interim injunction protecting the film’s IP - its ...

T-shirts emblazoned with powerful military quotes, particularly those from DGMO briefings, have become symbols of national pride, driving a surge in online merchandise sales. Thanks to Operation ...

Ben Verbrugge is a freelance sportswriter with a journalism degree from CSU Dominguez Hills. He is a member of the Los Angeles media and spends most of his time covering the NBA, NFL, and MLB ...

THOUSAND OAKS, Calif., May 16, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on Wednesday, May 21, 2025.

Amgen recently faced a legal setback, with a U.S. District Court jury finding the company liable for antitrust violations and awarding Regeneron Pharmaceuticals $406.8 million in damages.